Home > Boards > US Listed > Biotechs > Cel-Sci (CVM)

Funny how everyone loves Geert, then in one

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Spideyboy Member Profile
 
Followed By 17
Posts 974
Boards Moderated 0
Alias Born 04/07/08
160x600 placeholder
CEL-SCI Corporation Reports Third Quarter Fiscal 2021 Financial Results Business Wire - 8/16/2021 9:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/13/2021 4:19:36 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/7/2021 3:25:29 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/7/2021 10:51:52 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/7/2021 10:49:10 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/7/2021 10:45:24 AM
CEL-SCI says analysis of successful study arm was pre-specified in protocol Seeking Alpha - 7/7/2021 9:48:00 AM
CEL-SCI Corporation Issues Letter to Shareholders Business Wire - 7/7/2021 8:00:00 AM
CEL-SCI extends gains despite discussion on cancer trial Seeking Alpha - 7/2/2021 11:53:24 AM
Discussion of Results of CEL-SCI’s Phase 3 Trial Is Now Available Business Wire - 7/2/2021 11:20:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/2/2021 6:01:17 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/1/2021 9:13:04 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 7/1/2021 9:06:14 AM
Ocuphire Pharma, Predictive Oncology leads healthcare gainers; Altimmune, electroCore among major losers Seeking Alpha - 6/30/2021 11:03:36 AM
CEL-SCI to further discuss late-stage Multikine data in head and neck cancer Seeking Alpha - 6/30/2021 10:59:10 AM
CEL-SCI to Conduct Investor Call Regarding Phase 3 Results Following Annual Shareholder Meeting on July 1, 2021 Business Wire - 6/30/2021 9:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 6/29/2021 10:55:13 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/29/2021 8:30:14 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/28/2021 4:35:17 PM
CEL-SCI plummets 43% after phase 3 immunotherapy data misses primary endpoint Seeking Alpha - 6/28/2021 11:43:58 AM
CEL-SCI’s Multikine® Immunotherapy Produces Significant 14.1% 5-Year Survival Benefit (62.7% Vs 48.6%) in the Group Receiv... Business Wire - 6/28/2021 9:20:00 AM
CEL-SCI Corporation Invites Participants to Pre-Submit Questions for Annual Shareholder Meeting Business Wire - 6/25/2021 8:30:00 AM
CEL-SCI Announces the Closing of $31.7 Million Bought Deal Offering Business Wire - 6/11/2021 11:49:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/9/2021 4:09:46 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 6/9/2021 4:08:50 PM
Spideyboy   Friday, 02/28/20 02:27:42 AM
Re: None
Post # of 40544 
Funny how everyone loves Geert, then in one day, people start hating on him and so many new posters come out of the cracks to talk trash or nonsense.

The situation with the company itself is unchanged (less funds though), so would everyone calm down.

If this keeps up though, we're going to need another dilution next month.

Last December they raised enough for 1 additional quarter and I mentioned we'd likely need another one, and given the price drop and the Covid-19 turmoil on the markets it is likely difficult to convince warrant holders to convert at the moment.

I was expecting the strategy to be to get to results on the last raise, assuming Cel-Sci does have an understanding of the total number of events thus far, otherwise why only raise 1 quarter's worth of cash, but perhaps if ZSBiotech is correct then a new time-point of May 2020 has been put forward. Either-way a new raise pre-results is looking more likely now. I don't see why Cel-Sci doesn't open an ATM. They could take when they want at the higher market prices, especially as they are clearly going to need significantly more cash, pre and/or post-results.

However yes we should still take it as good news that the trial is still ongoing. Either the drug is amazing, or there's been a big mess up with type of patient recruitment, but that shouldn't be the case. I don't buy the concern on drop-outs either as the IDMC ought to have mentioned something on that by now.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences